The latest announcement is out from Natera ( (NTRA) ).
Natera, Inc. has announced the appointment of Monica Bertagnolli to its Board of Directors, effective March 6, 2025, increasing the board size from ten to eleven members. Dr. Bertagnolli, who previously served on the board from November 2020 to August 2022, will serve as a Class III director with a term expiring in 2027. Her appointment follows her tenure as Director of the National Cancer Institute, and she is recognized as an independent director under the Securities Act of 1933 and Nasdaq listing standards. Dr. Bertagnolli will also join the Nominating, Corporate Governance and Compliance Committee and will receive compensation similar to other non-employee directors. The company has also entered into an Indemnification Agreement with her, ensuring legal protection related to her service.
More about Natera
YTD Price Performance: -12.81%
Average Trading Volume: 1,628,703
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $18.93B
See more insights into NTRA stock on TipRanks’ Stock Analysis page.